Anogenital cancers testing in Lecce

Find health labs to test for Anogenital cancers in Lecce and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Laboratorio Lifebrain

Via Martiri D'Otranto, 2 73100 Lecce (Lecce)

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Don Bosco, 45 73100 LE (Lecce)

Unverified

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Corso Umberto I, 207 72026 San Pancrazio Salentino (BR)

18.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Giovanni Pascoli, 1 73040 Collepasso (LE)

19.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Uggiano, 29 74024 Manduria (TA)

28.5 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Fratelli Bandiera, 24 72024 Oria (BR)

29.5 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via XXIV Maggio, 54 74020 Lizzano (TA)

38.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Viale Matteotti, 51 74023 Grottaglie (TA)

41.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Dante Alighieri, 69 74026 Pulsano (TA)

43.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Circonvallazione dei Fiori, 255/Q 74122 Taranto (TA)

50.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Viale Virgilio, 97/A 74121 Taranto (TA)

50.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Berardi, 75/A/79 74100 Taranto (TA)

50.1 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.